{"organizations": [], "uuid": "f4d9ae595c6a8aa84e13b49a2a1bbdb5413ee6b1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180222.html", "section_title": "Archive News &amp; Video for Thursday, 22 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-mdxhealth-fy-total-revenue-up-35-p/brief-mdxhealth-fy-total-revenue-up-35-pct-at-40-million-dollars-idUSFWN1QC01F", "country": "US", "domain_rank": 408, "title": "BRIEF-Mdxhealth FY Total Revenue Up 35 pct at 40 Million Dollars", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.715, "site_type": "news", "published": "2018-02-22T15:26:00.000+02:00", "replies_count": 0, "uuid": "f4d9ae595c6a8aa84e13b49a2a1bbdb5413ee6b1"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-mdxhealth-fy-total-revenue-up-35-p/brief-mdxhealth-fy-total-revenue-up-35-pct-at-40-million-dollars-idUSFWN1QC01F", "ord_in_thread": 0, "title": "BRIEF-Mdxhealth FY Total Revenue Up 35 pct at 40 Million Dollars", "locations": [], "entities": {"persons": [{"name": "mdxhealth", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 22 (Reuters) - MDXHEALTH SA:\n* FY TOTAL REVENUE OF $40 MILLION UP 35% WITH CONTINUED STRONG VOLUME GROWTH\n* CASH AND CASH EQUIVALENTS OF $16.8 MILLION AS OF DECEMBER 31, 2017\n* FY EBITDA LOSS OF $10.4 MILLION VERSUS LOSS OF $ 11.1 MILLION YEAR AGO\n* FY NET LOSS $12.3 MILLION VERSUS LOSS OF $13.2 MILLION YEAR AGO\n* CLEAR FOCUS FOR MDXHEALTHâ€™S GROWTH IN 2018 AND BEYOND * ON CONFIRMMDX PRODUCT: SAYS DELIVERY OF PROJECTED NUMBER OF BILLABLE CASES FAILED TO MATERIALIZE DUE TO UNFORESEEN OPERATING ISSUES\n* ON CONFIRMMDX PRODUCT: THEREFORE EXPECTS A PORTION OF THE CASES TO ROLL OVER INTO 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-22T15:26:00.000+02:00", "crawled": "2018-02-23T15:51:56.019+02:00", "highlightTitle": ""}